Regeneron Pharmaceuticals REGN Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's short-term investments?
- Regeneron Pharmaceuticals (REGN) reported short-term investments of $5.79B in Q1 2026.
- How has Regeneron Pharmaceuticals's short-term investments changed year-over-year?
- Regeneron Pharmaceuticals's short-term investments increased by 10.1% year-over-year, from $5.26B to $5.79B.
- What is the long-term trend for Regeneron Pharmaceuticals's short-term investments?
- Over 5 years (2020 to 2025), Regeneron Pharmaceuticals's short-term investments has grown at a 31.5% compound annual growth rate (CAGR), from $1.39B to $5.49B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.